Cargando…
COVID-19 vaccine induced interstitial lung disease
A 60-year-old man presented with dyspnea four days after the second dose of the coronavirus disease (COVID-19) vaccine. Imaging revealed extensive ground-glass opacification. Blood tests were notable for elevated KL-6 levels. Bronchoalveolar lavage fluid analysis showed increased lymphocyte-dominant...
Autores principales: | Yoshifuji, Ayumi, Ishioka, Kota, Masuzawa, Yuya, Suda, Shuntaro, Murata, Saori, Uwamino, Yoshifumi, Fujino, Motoko, Miyahara, Hiromi, Hasegawa, Naoki, Ryuzaki, Munekazu, Hoshino, Haruhiko, Sekine, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450284/ https://www.ncbi.nlm.nih.gov/pubmed/34580010 http://dx.doi.org/10.1016/j.jiac.2021.09.010 |
Ejemplares similares
-
Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination
por: Uwamino, Yoshifumi, et al.
Publicado: (2023) -
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
por: Toda, Masataro, et al.
Publicado: (2021) -
Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
por: Toda, Masataro, et al.
Publicado: (2023) -
Chryseobacterium indologenes Peritonitis in a Peritoneal Dialysis Patient: A Case Report and Review of Literature
por: Miyakawa, Akira, et al.
Publicado: (2023) -
Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19
por: Toda, Masataro, et al.
Publicado: (2022)